Your browser doesn't support javascript.
loading
Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab.
Iannetta, Marco; Cesta, Novella; Stingone, Christof; Malagnino, Vincenzo; Teti, Elisabetta; Vitale, Pietro; De Simone, Giuseppe; Rossi, Benedetta; Ansaldo, Lorenzo; Compagno, Mirko; Spalliera, Ilaria; Di Lorenzo, Andrea; Landi, Doriana; Nicoletti, Carolina Gabri; Marfia, Girolama Alessandra; Andreoni, Massimo; Sarmati, Loredana.
Afiliação
  • Iannetta M; Department of System Medicine, Tor Vergata University, Rome, Italy; Infectious Disease Clinic, Policlinico Tor Vergata, Rome, Italy. Electronic address: marco.iannetta@uniroma2.it.
  • Cesta N; Department of System Medicine, Tor Vergata University, Rome, Italy.
  • Stingone C; Department of System Medicine, Tor Vergata University, Rome, Italy; Infectious Disease Clinic, Policlinico Tor Vergata, Rome, Italy.
  • Malagnino V; Department of System Medicine, Tor Vergata University, Rome, Italy; Infectious Disease Clinic, Policlinico Tor Vergata, Rome, Italy.
  • Teti E; Department of System Medicine, Tor Vergata University, Rome, Italy; Infectious Disease Clinic, Policlinico Tor Vergata, Rome, Italy.
  • Vitale P; Department of System Medicine, Tor Vergata University, Rome, Italy.
  • De Simone G; Department of System Medicine, Tor Vergata University, Rome, Italy.
  • Rossi B; Department of System Medicine, Tor Vergata University, Rome, Italy.
  • Ansaldo L; Department of System Medicine, Tor Vergata University, Rome, Italy.
  • Compagno M; Department of System Medicine, Tor Vergata University, Rome, Italy.
  • Spalliera I; Department of System Medicine, Tor Vergata University, Rome, Italy.
  • Di Lorenzo A; Department of System Medicine, Tor Vergata University, Rome, Italy.
  • Landi D; Department of System Medicine, Tor Vergata University, Rome, Italy; Multiple Sclerosis and Research Unit, Policlinico Tor Vergata, Rome, Italy.
  • Nicoletti CG; Department of System Medicine, Tor Vergata University, Rome, Italy; Multiple Sclerosis and Research Unit, Policlinico Tor Vergata, Rome, Italy.
  • Marfia GA; Department of System Medicine, Tor Vergata University, Rome, Italy; Multiple Sclerosis and Research Unit, Policlinico Tor Vergata, Rome, Italy.
  • Andreoni M; Department of System Medicine, Tor Vergata University, Rome, Italy; Infectious Disease Clinic, Policlinico Tor Vergata, Rome, Italy.
  • Sarmati L; Department of System Medicine, Tor Vergata University, Rome, Italy; Infectious Disease Clinic, Policlinico Tor Vergata, Rome, Italy.
Mult Scler Relat Disord ; 45: 102442, 2020 Oct.
Article em En | MEDLINE | ID: mdl-32777745
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Hospedeiro Imunocomprometido / Infecções por Coronavirus / Anticorpos Monoclonais Humanizados / Fatores Imunológicos / Esclerose Múltipla Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Hospedeiro Imunocomprometido / Infecções por Coronavirus / Anticorpos Monoclonais Humanizados / Fatores Imunológicos / Esclerose Múltipla Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article